Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oclassen Pharmaceuticals
San Rafael, California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Oclassen Pharmaceuticals developed and commercialized specialty prescription drugs for dermatology and infectious diseases, including the first patient-applied topical therapy for genital warts ("Condylox"), an oral antibiotic for acne ("Monodox"), and topical corticosteroids. The company also licensed wound care products such as Iodosorb Gel. It was acquired by Watson Pharmaceuticals in 1997.
- Therapeutic areas
- DermatologyInfectious Diseases
- Modalities
- Small moleculeTopical therapyOral antibioticCorticosteroid (Small molecule)
- Industry
- Biotech
02
Partnerships
Perstorp Pharma – licensing agreement for wound care products
Beyond the preview
Go deeper on Oclassen Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Oclassen Pharmaceuticals.